Small Organic Compounds Enhance Antigen Loading of Class II Major Histocompatibility Complex Proteins by Targeting the Polymorphic P1 Pocket*♦

Major histocompatibility complex (MHC) molecules are a key element of the cellular immune response. Encoded by the MHC they are a family of highly polymorphic peptide receptors presenting peptide antigens for the surveillance by T cells. We have shown that certain organic compounds can amplify immune responses by catalyzing the peptide loading of human class II MHC molecules HLA-DR. Here we show now that they achieve this by interacting with a defined binding site of the HLA-DR peptide receptor. Screening of a compound library revealed a set of adamantane derivatives that strongly accelerated the peptide loading rate. The effect was evident only for an allelic subset and strictly correlated with the presence of glycine at the dimorphic position β86 of the HLA-DR molecule. The residue forms the floor of the conserved pocket P1, located in the peptide binding site of MHC molecule. Apparently, transient occupation of this pocket by the organic compound stabilizes the peptide-receptive conformation permitting rapid antigen loading. This interaction appeared restricted to the larger Glyβ86 pocket and allowed striking enhancements of T cell responses for antigens presented by these “adamantyl-susceptible” MHC molecules. As catalysts of antigen loading, compounds targeting P1 may be useful molecular tools to amplify the immune response. The observation, however, that the ligand repertoire can be affected through polymorphic sites form the outside may also imply that environmental factors could induce allergic or autoimmune reactions in an allele-selective manner.

[1]  O. Rötzschke,et al.  “Chemical Analogues” of HLA-DM Can Induce a Peptide-receptive State in HLA-DR Molecules* , 2004, Journal of Biological Chemistry.

[2]  F. Sinigaglia,et al.  Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.

[3]  L. Santambrogio,et al.  Abundant empty class II MHC molecules on the surface of immature dendritic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Stewart,et al.  The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients. , 1999, Human immunology.

[5]  C. Watts,et al.  Antigen processing in the endocytic compartment. , 2001, Current opinion in immunology.

[6]  Scheherazade Sadegh-Nasseri,et al.  Hla-Dm Recognizes the Flexible Conformation of Major Histocompatibility Complex Class II , 2000, The Journal of experimental medicine.

[7]  J. Strominger,et al.  Extracellular antigen processing and presentation by immature dendritic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. D'cruz Autoimmune diseases associated with drugs, chemicals and environmental factors. , 2000, Toxicology letters.

[9]  Antonio Lanzavecchia,et al.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells , 1997, Nature.

[10]  Lawrence Steinman,et al.  T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.

[11]  J. Todd,et al.  HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.

[12]  L. Stern,et al.  A three-step kinetic mechanism for peptide binding to MHC class II proteins. , 2000, Biochemistry.

[13]  Timothy J Mitchison,et al.  Noble metals strip peptides from class II MHC proteins , 2006, Nature chemical biology.

[14]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[15]  O. Rötzschke,et al.  Small-molecular compounds enhance the loading of APC with encephalitogenic MBP protein. , 2003, Journal of autoimmunity.

[16]  N. Balandraud,et al.  Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. , 2003, Human immunology.

[17]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[18]  Hans-Georg Rammensee,et al.  MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.

[19]  B. Evavold,et al.  Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.

[20]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[21]  D. Wiley,et al.  MHC class II function preserved by low-affinity peptide interactions preceding stable binding , 1994, Nature.

[22]  K. Ballingall,et al.  The DY sub-region of the sheep MHC contains an A/B gene pair , 2004, Immunogenetics.

[23]  J. Woody,et al.  Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin , 1982, Nature.

[24]  K. Wucherpfennig,et al.  Small Molecules That Enhance the Catalytic Efficiency of HLA-DM1 , 2006, The Journal of Immunology.

[25]  R. Karr,et al.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.

[26]  A. Woods,et al.  An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen , 1997, The Journal of experimental medicine.

[27]  H. Ploegh,et al.  Translating cell biology in vitro to immunity in vivo , 2004, Nature.

[28]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[29]  Lars Fugger,et al.  MHC class II proteins and disease: a structural perspective , 2006, Nature Reviews Immunology.

[30]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[31]  J. Strominger,et al.  Ligand Exchange of Major Histocompatibility Complex Class II Proteins Is Triggered by H-bond Donor Groups of Small Molecules* , 2002, The Journal of Biological Chemistry.

[32]  M. Vrljic,et al.  Formation of a highly peptide-receptive state of class II MHC. , 1998, Immunity.

[33]  Don C. Wiley,et al.  Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein , 1998, The Journal of experimental medicine.

[34]  P Wordsworth,et al.  Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.